Articles On Telix Pharmaceuticals (ASX:TLX)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin ASX200 futures are pointing to another positive open, post a flattish performance on...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin New approval provides French hospitals and clinics with access to a proven PSMA...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a positive fashion. The benchmark index rose 0.35% to 7,997.1 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected...

In this week’s video insight, I discuss the growth of Telix Pharmaceuticals (ASX:TLX). When the Montgomery Fund, The Montgomery [Private] Fund, and the Australian Eagle Trust Long Short Funds first invested in TLX, the share price was aroun...

Highlights ASX extends rally with strong gains across sectors. Tech stocks mirror Wall Street’s upbeat performance. Banks bolster the market while miners lag. The Australian share market notched its third consecutive session of ga...

Highlights: ASX opens higher, buoyed by Wall Street’s rally and hopes of China stimulus. Tech stocks lead the charge on ASX, with NextDC posting notable gains. Telix experiences a setback as FDA decision impacts stock perfor...

Telix (ASX:TLX) has copped a sharp jab on Monday as the FDA says its drug TLX101-CDx, AKA Floretyrosine, can’t be accepted for imaging the rare brain cancer glioma. In short, the US regulator is asking for more data from Telix with rega...

The ASX200 has been up 0.8% at 8,032 points in early afternoon trades. Telix Pharmaceuticals (ASX:TLX) has been among the most watched on HotCopper forums today after the US Food and Drug Administration ruled the company’s New Drug Appli...

The FDA has told Telix to do more work on its imaging agent for rare brain cancers But the agency tells Dimerix it can use a surrogate endpoint for its kidney disease drug candidate Emvision opens a second US site to test its stroke detect...

Highlights ASX lifted by strength in banks and tech sectors. Telix Pharmaceuticals drops on regulatory setback. Miners lag as iron ore prices slip. The Australian sharemarket advanced firmly into positive territory, buoyed by gain...

Highlights  ASX rises 1% amid China stimulus hopes  Technology sector leads local market gains  Telix tumbles after US regulatory setback  Australia's sharemarket opened the week on a strong note, lifted by optimism around potenti...

The S&P/ASX 200 Index (ASX: XJO) is starting the week on a positive note. At the time of writing, the benchmark index is up 0.7% to 8,023.9 points. Four ASX shares that have failed to follow the market higher today are listed below. He...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are tumbling on Monday morning. At the time of writing, the radiopharmaceuticals company's shares are down 8% to $26.35. Why are Telix shares sinking? Investors have been selling the company's sha...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is under the spotlight after announcing a negative update from the US FDA. Telix Pharmaceuticals describes itself as a biopharmaceutical company that’s focused on the development and comm...

Every now and again, an ASX company emerges that captures the hearts and minds of investors.  It doesn't happen every year, but it certainly happens more often than you think.  From Droneshield (ASX: DRO) to ProMedicus (ASX: PME) to S...

ASX heath sector up 1.9%, trailing ASX 200’s 2% gain in short week revival   Sleep-related respiratory disorders company ResMed reports “stronger than expected” Q3 FY25 results Imricor makes key regulatory strides in Q1 CY25, including sub...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was on form and stormed higher. The benchmark index rose 1.3% to 7,920.5 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200 expected to r...

Key Highlights: Examine the role of global economic shifts on stocks like BHP Group (ASX:BHP) and Coles Group (ASX:COL) in the ASX. Review sector performances with a focus on gains in energy and mixed results in materials. H...

Highlights: ASX lifted by gains in energy and tech sectors following tariff updates from the US Gold miners dragged by falling spot gold prices after record highs Capricorn Metals and BHP moved on executive updates, while Pa...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a hump day boost this Wednesday, rocketing higher following a surge of optimism out of the United States. By the time trading wrapped up today, the ASX 200...

Trump backs off tariffs and markets breathe easier Musk will spend more time at Tesla after a shocker quarter Gold miners smashed as traders cash in on record highs   The ASX rallied by about 1.5% on Wednesday, riding a wave of optimism f...

Highlights: The ASX200 advanced sharply, led by gains in the energy and health care sectors Uranium-related shares recorded significant upward movements during the session Gold miners faced pressure amid a shift in sentiment...

Highlights ASX rises strongly amid optimism over easing US-China trade tensions Energy and healthcare sectors post notable gains during early trade Gold segment experiences downturn as risk appetite shifts The Australi...

Highlights: ASX 200 index advanced, supported by mining and pharmaceutical sector developments. Paladin Energy and Telix Pharmaceuticals reported operational and financial updates. Trigg Minerals appointed new leadership to...

The ASX 200 has been in a positive mood today, up 1.60% at 7,941 points in early afternoon trades. Paladin Energy (ASX:PDN) has been among the most watched on the HotCopper forums this morning. The stock has risen by more than 25% on new...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.6% to 7,942.8 points. Four ASX shares that are rising more than most today are listed below....

Highlights ASX surges on hopes of tariff relief and Wall Street momentum Energy, tech, and mining stocks lead gains; gold stocks retreat Paladin Energy shines with record uranium output Australian shares rallied strongly mid-week,...

It's a great day on the S&P/ASX 200 Index (ASX: XJO) today. At the time of writing, the benchmark Aussie index is up 1.6% at 7,939.1 points. ASX 200 uranium stock Paladin Energy Ltd (ASX: PDN) is leading the charge, with shares up 21.6%...

Highlights  ASX jumps nearly 2% on Wall Street rally and US tariff rollback signals  Resource and tech stocks post strong gains amid easing trade concerns  Telix, Paladin shine with major updates; Cettire tumbles on weak demand  A...

Telix’s quarterly sales reflect first revenue from the company’s recent purchase of a US nuclear medicine manufacturer Island Pharma hopes to lift the kimono on its dengue fever trial next month Race Oncology kicks off its cancer-busting,...

Highlights  ASX opens with a sharp gain following Wall Street momentum  Paladin Energy leads with record quarterly output  Gold stocks retreat as prices peak above $US3500/oz  Australian shares climbed sharply in early trade, lift...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are catching the eye on Wednesday morning. At the time of writing, the ASX 200 biotech company's shares are up 15% to $28.95. Telix shares rocket on Q1 update Investors have been buying the compan...

Highlights  ASX 200 futures rise over 1.2% following a broad-based US market rebound  Global sentiment boosted by signs of progress in trade negotiations with Japan and India  Gold stocks ease, while growth-oriented sectors and tech E...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) started the shortened week with a small decline. The benchmark index edged slightly lower to 7,816.7 points. Will the market be able to bounce back from this on Wednesday? Here are five thi...

Highlights: Nextdc operates data centres across the Asia-Pacific, supporting cloud and AI infrastructure Telix Pharmaceuticals develops radiopharmaceuticals for oncology imaging and therapy Both companies continue to expand...

If you are lucky enough to have $10,000 to invest and also have a penchant for ASX growth shares, then read on! That's because listed below are three fantastic shares that analysts are tipping to grow strongly in the coming years. Here's wh...

Highlights James Hardie Industries continues to benefit from rising demand for fibre cement in North America ResMed maintains market presence with its respiratory care product portfolio and recurring revenue base Telix Pharm...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 /PRNewswire/ — Telix Pharma...

If you are on the lookout for some investment ideas, then it could be worth checking out what analysts saying. Listed below are five ASX 200 stocks that leading brokers currently rate as buy. Here's what they are recommending to clients: J...

With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX. Analysts at Bell Potter have recently named a select group of ASX shares they...

On Friday, the S&P/ASX 200 Index (ASX: XJO) ended the week in the red. The benchmark index dropped 0.8% to 7,646.5 points. Will the market be able to bounce back from this on Monday? Here are five things to watch: ASX 200 expected to...

Donald Trump’s latest tariff bombshell has shaken global markets and it’s raising serious questions. Was this chaos just bad policy… or something more calculated? Listen to the HotCopper podcast for in-depth discussions and insights on a...

Highlights: Financial sector unchanged by midday as broader market trends lower Regal Partners reports a decline in funds under management over the quarter Healthcare sector leads losses amid tariff concerns and industry dev...

Highlights: ASX lifts sharply with all sectors closing higher, rebounding from prior session declines Nikkei records strong movement as markets respond to tariff rhetoric Resource and tech firms lead gains, while a few small...

ASX rallies 2.27% after shedding 4% yesterday Nikkei225 soars almost 6%, recovering from Monday’s losses Trade war threatens to escalate as China calls tariff escalations ‘a mistake’.   The ASX posted a strong gain to rise 2.27% today, re...

It was a stunning recovery day for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Tuesday. After the carnage that kicked off the trading week yesterday, investors were clearly in the mo...

Highlights: ASX index experiences its heaviest single-day loss since the early pandemic period Commodity prices, including gold and copper, decline sharply as global markets reel Buyout proposal drives significant gains for...

Companies including Cochlear and Telix affirm that tariffs are likely to be a ‘Y2K’ non-event Bell Potter says Trajan shares are worth double their current price Plucky Biotron lives another day after passing the hat   On the evening of D...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Tariff rumours whipsawed the S&P500 over an 8.5% range from trough-to-peak over...

Highlights: Lynas Rare Earths and Nyrada advanced while most sectors declined Abacus Storage King surged following a major acquisition proposal Woodside Energy and Kelsian Group posted declines despite business developments...